Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project?

被引：4
作者：
Bala, Gezim [1 ,2 ]
Broisat, Alexis [3 ]
Lahoutte, Tony [1 ,4 ]
Hernot, Sophie [1 ]
机构：
[1] Vrije Univ Brussel, Vivo Cellular & Mol Imaging ICMI BEFY, Brussels, Belgium
[2] UZ Brussel, Dept Cardiol, Brussels, Belgium
[3] 1039 Univ Grenoble, INSERM, Radiopharmaceut Bioclin, La Tronche, France
[4] UZ Brussel, Dept Nucl Med, Brussels, Belgium
来源：
MOLECULAR IMAGING AND BIOLOGY | 2018年 / 20卷 / 03期
关键词：
Atherosclerosis; Vulnerable plaque imaging; Translational medicine; Molecular imaging; HIGH-RISK PATIENTS; PCSK9; INHIBITORS; ATHEROSCLEROSIS; INFLAMMATION; RATIONALE; EVENTS; DESIGN; PET;
D O I：
10.1007/s11307-017-1147-x
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：337 / 339
页数：3
相关论文
共 23 条
  • [1] Acute Coronary Events
    Arbab-Zadeh, Armin
    Nakano, Masataka
    Virmani, Renu
    Fuster, Valentin
    [J]. CIRCULATION, 2012, 125 (09) : 1147 - 1156
  • [2] Emerging anti-inflammatory drugs for atherosclerosis
    Berman, Jeremy P.
    Farkouh, Michael E.
    Rosenson, Robert S.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (02) : 193 - 205
  • [3] BIOCHEMISTRY TO BEHAVIOUR
    Cannon, Bill
    [J]. NATURE, 2013, 493 (7434) : S2 - S3
  • [4] Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: A Pathologic study
    Cheruvu, Pavan K.
    Finn, Aloke V.
    Gardner, Craig
    Caplan, Jay
    Goldstein, James
    Stone, Gregg W.
    Virmani, Renu
    Muller, James E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (10) : 940 - 949
  • [5] PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumab
    Dahagam, Chanukya
    Goud, Aditya
    Abdelqader, Abdelhai
    Hendrani, Aditya
    Feinstein, Matthew J.
    Qamar, Arman
    Joshi, Parag H.
    Swiger, Kristopher J.
    Byrne, Kathleen
    Quispe, Renato
    Jones, Steven R.
    Blumenthal, Roger S.
    Martin, Seth S.
    [J]. FUTURE CARDIOLOGY, 2016, 12 (02) : 139 - 148
  • [6] PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumab
    Dahagam, Chanukya
    Goud, Aditya
    Abdelqader, Abdelhai
    Hendrani, Aditya
    Feinstein, Matthew J.
    Qamar, Arman
    Joshi, Parag H.
    Swiger, Kristopher J.
    Byrne, Kathleen
    Quispe, Renato
    Jones, Steven R.
    Blumenthal, Roger S.
    Martin, Seth S.
    [J]. FUTURE CARDIOLOGY, 2016, 12 (02) : 149 - 157
  • [7] Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis
    Dweck, Marc R.
    Aikawa, Elena
    Newby, David E.
    Tarkin, Jason M.
    Rudd, James H. F.
    Narula, Jagat
    Fayad, Zahi A.
    [J]. CIRCULATION RESEARCH, 2016, 119 (02) : 330 - 340
  • [8] Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
    Everett, Brendan M.
    Pradhan, Aruna D.
    Solomon, Daniel H.
    Paynter, Nina
    MacFadyen, Jean
    Zaharris, Elaine
    Gupta, Milan
    Clearfield, Michael
    Libby, Peter
    Hasan, Ahmed A. K.
    Glynn, Robert J.
    Ridker, Paul M.
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (02) : 199 - +
  • [9] Concept of Vulnerable/Unstable Plaque
    Finn, Aloke V.
    Nakano, Masataka
    Narula, Jagat
    Kolodgie, Frank D.
    Virmani, Renu
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (07) : 1282 - 1292
  • [10] 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
    Joshi, Nikhil V.
    Vesey, Alex T.
    Williams, Michelle C.
    Shah, Anoop S. V.
    Calvert, Patrick A.
    Craighead, Felicity H. M.
    Yeoh, Su Ern
    Wallace, William
    Salter, Donald
    Fletcher, Alison M.
    van Beek, Edwin J. R.
    Flapan, Andrew D.
    Uren, Neal G.
    Behan, Miles W. H.
    Cruden, Nicholas L. M.
    Mills, Nicholas L.
    Fox, Keith A. A.
    Rudd, James H. F.
    Dweck, Marc R.
    Newby, David E.
    [J]. LANCET, 2014, 383 (9918) : 705 - 713
123